<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-32720" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Anhidrosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Harper</surname>
            <given-names>Chelsea D.</given-names>
          </name>
          <aff>Campbell University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bermudez</surname>
            <given-names>Rene</given-names>
          </name>
          <aff>Sampson Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chelsea Harper declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rene Bermudez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>21</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-32720.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Anhidrosis is the inability to sweat. It is important to recognize anhidrosis as it can be potentially life-threatening due to heat-related illnesses. There are three main causes of anhidrosis, which are peripheral alterations in the eccrine gland itself, idiopathic, and central or neuropathic disease and/or medication that disrupts neural inputs from the anterior hypothalamus to the gland. This activity reviews the etiology and evaluation of anhidrosis and highlights the role of the interprofessional team in evaluating and improving care for patients with anhidrosis.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of anhidrosis.</p></list-item><list-item><p>Outline the evaluation of anhidrosis.</p></list-item><list-item><p>Review the management options available for anhidrosis.</p></list-item><list-item><p>Describe the interprofessional team strategies for improving care coordination and communication to advance care and improve outcomes for patients with anhidrosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=32720&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=32720">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-32720.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Anhidrosis is the inability to sweat. It is important to recognize anhidrosis as it can be potentially life-threatening due to heat-related illnesses.<xref ref-type="bibr" rid="article-32720.r1">[1]</xref>&#x000a0;There are three main&#x000a0;causes of anhidrosis, which are peripheral alterations in the eccrine gland itself, idiopathic, and central or neuropathic disease and/or medication that disrupts neural inputs from the anterior hypothalamus to the gland.<xref ref-type="bibr" rid="article-32720.r2">[2]</xref></p>
        <p>Causes of central/neuropathic anhidrosis can occur at any level of innervation.<xref ref-type="bibr" rid="article-32720.r3">[3]</xref>&#x000a0;The disturbance can occur at the sweating center in the brain, the descending neural tract, or the sweat gland. A disruption will lead to an absence of sweating. Disruption in the neural input can be due to tumors or infarctions of the hypothalamus, pons, or medulla. Spinal cord tumors, injuries, or infarctions can disrupt the neural tract.<xref ref-type="bibr" rid="article-32720.r4">[4]</xref>&#x000a0;Other etiologies such as degenerative syndromes (Shy-Drager syndrome), autoimmune autonomic neuropathy, peripheral neuropathy (diabetes, alcohol use disorder, leprosy), and drugs have all been implicated in central/neuropathic anhidrosis.<xref ref-type="bibr" rid="article-32720.r5">[5]</xref></p>
        <p>Peripheral alterations that cause anhidrosis can be congenital or acquired. In addition, forms of peripheral alterations can be due to genetic abnormalities such as incontinentia pigmenti, due to local destruction, for example, by a tumor, or obstruction by entities such as psoriasis.</p>
        <p>As heat intolerance may be due to various underlying disorders, a detailed history is important in establishing the diagnosis. Heat intolerance can cause drowsiness, episodic inability to concentrate while in a hot environment, or fatigue, along with a decrease in the patient's normal sweating, which are clues to the diagnosis of anhidrosis. A detailed history should also include the addition of medications, medical events such as injuries, growths or radiation, alcohol consumption, the presence of autoimmune disease or diabetes mellitus, and family history.<xref ref-type="bibr" rid="article-32720.r2">[2]</xref></p>
      </sec>
      <sec id="article-32720.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Central and neuropathic causes of anhidrosis can occur anywhere along the neural track, as previously stated. There are diagnostic clues that will aid in locating the area of the lesion. If there is the involvement of the pons or medulla, the patient will have ipsilateral facial and neck anhidrosis.<xref ref-type="bibr" rid="article-32720.r6">[6]</xref>&#x000a0;Neural tracks in the spinal cord have both crossed and uncrossed fibers. Therefore, alterations in the spinal cord will result in anhidrosis of the skin that can be either ipsilateral or contralateral.&#x000a0;Peripheral neuropathies tend to be symmetrical as in diabetes mellitus and alcohol use disorder.<xref ref-type="bibr" rid="article-32720.r7">[7]</xref>&#x000a0;However, there are cases of asymmetrical peripheral neuropathy leading to anhidrosis, such as in cases of leprosy. A patient with Horner syndrome will present after the disruption of the superior cervical ganglion. Regional anhidrosis can also occur due to the chemical blockade of a selected sympathetic ganglion. Congenital insensitivity to&#x000a0;pain with anhidrosis is a rare entity that is autosomal and recessive. It presents with self-mutilation due to a lack of pain, intellectual disability, and recurrent fevers due to anhidrosis.<xref ref-type="bibr" rid="article-32720.r8">[8]</xref><xref ref-type="bibr" rid="article-32720.r9">[9]</xref></p>
        <p>Drugs that&#x000a0;interfere with&#x000a0;the synaptic transmission in the autonomic ganglia will lead to anhidrosis:<xref ref-type="bibr" rid="article-32720.r10">[10]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Nicotinic acetylcholine receptor antagonists such as hexamethonium and trimethaphan</p>
          </list-item>
          <list-item>
            <p>Muscarinic acetylcholine receptor antagonists such as atropine or scopolamine</p>
          </list-item>
          <list-item>
            <p>Calcium channel blockers</p>
          </list-item>
          <list-item>
            <p>Alpha-adrenergic blockers such as phentolamine</p>
          </list-item>
          <list-item>
            <p>Alpha2-adrenergic agonists such as clonidine</p>
          </list-item>
          <list-item>
            <p>5-fluorouracil</p>
          </list-item>
          <list-item>
            <p>Topiramate</p>
          </list-item>
          <list-item>
            <p>Zonisamide</p>
          </list-item>
          <list-item>
            <p>Quinacrine</p>
          </list-item>
        </list>
        <p>There are numerous causes of abnormalities in the sweat gland that cause anhidrosis. Among the various causes are several hereditary and acquired systemic diseases that present with generalized or localized anhidrosis.&#x000a0;Males with X-linked hypohidrotic ectodermal dysplasia will have an absence of sweat glands, whereas female carriers will have hypohidrosis or reduced sweating.<xref ref-type="bibr" rid="article-32720.r11">[11]</xref><xref ref-type="bibr" rid="article-32720.r12">[12]</xref>&#x000a0;The other ectodermal dysplasias, such as Rapp-Hodgkin syndrome and Naegeli-Franceschetti-Jadassohn syndrome, can lead to sweat gland abnormalities.<xref ref-type="bibr" rid="article-32720.r13">[13]</xref> Though not an exhaustive list, there are other rare inherited syndromes in which genetic errors result in sweat gland dysfunction such as Bazex-Dupre-Christol syndrome and Fabry disease.<xref ref-type="bibr" rid="article-32720.r14">[14]</xref></p>
        <p>Local tissue destruction can be the culprit of acquired localized anhidrosis. Tumors, radiation therapy, systemic sclerosis, burns, graft-versus-host disease, acrodermatitis chronica atrophicans, and Sj&#x000f6;gren&#x000a0;syndrome can distort the normal architecture of the skin with subsequent anhidrosis. Entities that lead to obstruction of the glands are also implicated in anhidrosis. Psoriasis, lamellar ichthyosis, miliaria, eczematous dermatoses, porokeratosis, and bullous diseases are examples of obstruction.<xref ref-type="bibr" rid="article-32720.r15">[15]</xref></p>
      </sec>
      <sec id="article-32720.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Anhidrosis is a clinical finding and not a distinct entity. The exact epidemiology will depend on the underlying etiology. In the majority of&#x000a0;anhidrosis&#x000a0;cases, men and women are equally affected, with a few exceptions. The age of presentation will vary based on the underlying etiology. Horner syndrome is one of the causes of anhidrosis&#x000a0;and&#x000a0;is an uncommon condition, occurring with a frequency of approximately 1 per 6,000. It may occur at any age or with any ethnic group.<xref ref-type="bibr" rid="article-32720.r16">[16]</xref><xref ref-type="bibr" rid="article-32720.r17">[17]</xref>&#x000a0;</p>
        <p>Another cause of hypohidrosis/anhidrosis is hypohidrotic ectodermal dysplasia, in which patients either do not have eccrine sweat glands or are sparse and rudimentary. In the US, the prevalence of hypohidrotic ectodermal dysplasia is estimated to be 1 per 100,000 births. Internationally,&#x000a0;the prevalence is reported at 7 cases per 10,000 births.&#x000a0;</p>
        <p>Naegeli-Franceschetti-Jadassohn (NFJ) syndrome is also a rare cause of anhidrosis and is reported to have an international prevalence of around 1 case in 2-4 million population.<xref ref-type="bibr" rid="article-32720.r18">[18]</xref><xref ref-type="bibr" rid="article-32720.r19">[19]</xref>&#x000a0;Fabry disease is another disorder where there is a lack of sweat glands, and its prevalence has been&#x000a0;observed to be 1 per 40,000 people.<xref ref-type="bibr" rid="article-32720.r20">[20]</xref>&#x000a0;There are many other disorders that present with anhidrosis and have&#x000a0;variable epidemiological indicators.</p>
      </sec>
      <sec id="article-32720.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of&#x000a0;anhidrosis varies depending on the etiology, as anhidrosis is a clinical finding and not a distinct entity. For central and neuropathic anhidrosis, interruption of innervation at any level along the pathway from the sweating centers located in the brain to the sweat glands can result in absent sweating. Drugs that interfere with the synaptic transmission in the autonomic ganglia can inhibit sweating. Peripheral alterations can result in the absence of sweating. Peripheral alterations include genetic disorders, destruction, or obstruction. Genetic abnormalities underlie several types of anhidrosis, and the pathogenesis may be unknown. Other etiologies may have a known cause, such as local tissue destruction by prior radiation therapy. The clinical presentation and history can help delineate the pathophysiology.<xref ref-type="bibr" rid="article-32720.r21">[21]</xref>&#x000a0;</p>
        <p>As anhidrosis is a clinical presentation of an underlying disorder, it is beyond the scope to describe the pathophysiology of each disorder separately. However, for instance, Horner syndrome, which is a common cause of ipsilateral anhidrosis, depends on the level of interruption of the sympathetic supply. Anhidrosis with first-order neuron lesions affects the ipsilateral side of the body as the sympathetic supply from its central origin. The ipsilateral face is involved in lesions involving the second-order neurons. Postganglionic third-order neuron lesions occurring after the vasomotor and sudomotor fibers have branched off show very&#x000a0;limited involvement of the face (area adjacent to the ipsilateral brow).<xref ref-type="bibr" rid="article-32720.r22">[22]</xref></p>
      </sec>
      <sec id="article-32720.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histopathology will vary depending on the etiology.&#x000a0;Males with X-linked hypohidrotic ectodermal dysplasia will have an absence of sweat glands, whereas female carriers will have reduced glands. The clinical presentation and or a skin biopsy will help identify those with local destruction or obstruction.<xref ref-type="bibr" rid="article-32720.r23">[23]</xref></p>
        <p>Light microscopy may not reveal marked morphological changes in sweat glands in patients with acquired idiopathic generalized anhidrosis (AIGA) due to idiopathic pure sudomotor failure (IPSF). Still, there may be lymphocytic infiltration around sweat glands.<xref ref-type="bibr" rid="article-32720.r24">[24]</xref> Some cases of AIGA may&#x000a0;reveal swollen secretory cells of the sweat glands and hyperkeratotic horny layer due to sweat gland failure.</p>
      </sec>
      <sec id="article-32720.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>History and physical exam findings for anhidrosis will&#x000a0;differ between the various underlying etiologies. A thorough history should be obtained, including past medical history, medications, medical treatments (i.e., radiation therapy), and family history. A careful and detailed history will yield clues to a potential diagnosis.<xref ref-type="bibr" rid="article-32720.r9">[9]</xref></p>
        <p>A patient may complain of heat intolerance, fatigue, drowsiness, or inability to concentrate in warm environments. A patient with central/neuropathic anhidrosis may have accompanying neurological symptoms such as ptosis and miosis in Horner syndrome. Although very rare, a patient with congenital insensitivity to pain with anhidrosis will present with self-mutilation.</p>
        <p>Those&#x000a0;with anhidrosis due to&#x000a0;destruction will have the physical exam findings of the underlying etiology, such as scarring from a prior burn or sclerotic changes as in morphea.</p>
        <p>Anhidrosis caused by obstruction will likewise have the physical exam findings associated with the underlying etiology, such as psoriatic plaques or lamellar ichthyosis.</p>
      </sec>
      <sec id="article-32720.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Detailed patient history is paramount in determining the possible underlying etiology.&#x000a0;The next step would be to determine any potential contributing factors, such as medications. Colorimetric and or gravimetric testing can demonstrate diminished or absent sweating. Injection of local, intradermal cholinergic drugs to promote sweating can be utilized. However, this should only be done in a small area as the side effect profile and its associated risks preclude injection into large areas. If a patient is suspected of having peripheral neuropathy, testing the axon reflex sweating by injecting an intradermal picrate or&#x000a0;nicotine sulfate at an appropriate dose may be performed. A skin biopsy from an affected area should always be obtained in patients with suspected anhidrosis to identify abnormalities of the sweat glands.</p>
        <p>A quantitative sudomotor axon reflex test (QSART) assesses&#x000a0;the autonomic nerves that mediate sweating.<xref ref-type="bibr" rid="article-32720.r25">[25]</xref>&#x000a0;Mild electrical stimulation is applied to the skin via electrodes and acetylcholine enters the skin. Acetylcholine results in the stimulation of the sweat glands; and the sweat response is measured.</p>
        <p>A silastic sweat imprint test also utilizes electrodes, however, pilocarpine is used to stimulate the sweat glands. indentations appear to mark the sweat droplets on a material formed of silicone rubber.<xref ref-type="bibr" rid="article-32720.r26">[26]</xref></p>
        <p>A thermoregulatory sweat test utilizes the body's core temperature to assess a correlation to sweat production. It assesses the thermo-regulatory sudomotor&#x000a0;mechanism of the body.<xref ref-type="bibr" rid="article-32720.r27">[27]</xref></p>
      </sec>
      <sec id="article-32720.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Unfortunately, treatment options for anhidrosis can be limited unless an offending agent can be discontinued. Providers need to stress the importance of maintaining a cool environment for the patient.&#x000a0;The use of&#x000a0;water spray bottles for purposes of cooling can prove helpful. For those disorders due to clogged sweat glands, frequent and gentle exfoliation is&#x000a0;useful. Those with disorders of cornification and overheating, such as lamellar ichthyosis, should be treated aggressively and monitored closely.</p>
        <p>Although there is no remarkable evidence to support the use of corticosteroids,&#x000a0;many case reports recommend the administration of corticosteroids&#x000a0;in the early stages of AIGA.<xref ref-type="bibr" rid="article-32720.r28">[28]</xref>&#x000a0;However, if the treatment is delayed or when the destruction of sweat glands has already occurred, then corticosteroids may not be beneficial.</p>
        <p>The cornerstone for the treatment of anhidrosis is the management of the underlying cause, such as treating lung carcinoma if that is causing Horner syndrome and resulting in anhidrosis.</p>
      </sec>
      <sec id="article-32720.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>When considering anhidrosis, a differential diagnosis will depend on the underlying etiology.</p>
        <p>
<bold>Central and Neuropathic Anhidrosis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tumors, infarctions, or other alterations of the hypothalamus, pons, medulla, or spinal cord</p>
          </list-item>
          <list-item>
            <p>Horner syndrome</p>
          </list-item>
          <list-item>
            <p>Degenerative syndromes such as Ross syndrome or Shy-Drager syndrome</p>
          </list-item>
          <list-item>
            <p>Autoimmune autonomic neuropathy</p>
          </list-item>
          <list-item>
            <p>Congenital insensitivity to pain with anhidrosis</p>
          </list-item>
          <list-item>
            <p>Peripheral neuropathy due to diabetes mellitus, alcoholism, leprosy, amyloidosis</p>
          </list-item>
          <list-item>
            <p>Drugs</p>
          </list-item>
        </list>
        <p>
<bold>Drugs</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Nicotinic acetylcholine receptor antagonists such as hexamethonium and trimethaphan</p>
          </list-item>
          <list-item>
            <p>Muscarinic acetylcholine receptor antagonists such as atropine or scopolamine</p>
          </list-item>
          <list-item>
            <p>Calcium channel blockers</p>
          </list-item>
          <list-item>
            <p>Alpha-adrenergic blockers such as phentolamine</p>
          </list-item>
          <list-item>
            <p>Alpha2-adrenergic agonists such as clonidine</p>
          </list-item>
          <list-item>
            <p>5-fluorouracil</p>
          </list-item>
          <list-item>
            <p>Topiramate</p>
          </list-item>
          <list-item>
            <p>Zonisamide</p>
          </list-item>
          <list-item>
            <p>Quinacrine</p>
          </list-item>
        </list>
        <p>
<bold>Peripheral Causes Due to Sweat Gland Abnormalities</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Genetic disorders such as ectodermal dysplasias, incontinentia pigmenti, Bazex-Dupr&#x000e9;-Christol syndrome, Fabry disease</p>
          </list-item>
          <list-item>
            <p>Destruction from tumors, burns, radiation therapy, systemic sclerosis, morphea, Sj&#x000f6;gren syndrome, graft-versus-host disease, acrodermatitis chronica atrophicans</p>
          </list-item>
          <list-item>
            <p>Obstruction from miliaria, ichthyoses, psoriasis, eczematous dermatoses, bullous diseases</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-32720.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of&#x000a0;anhidrosis&#x000a0;varies depending on the type of&#x000a0;anhidrosis.&#x000a0;Anhidrosis&#x000a0;associated with a genetic syndrome is generally&#x000a0;lifelong. In the setting of drug-induced&#x000a0;anhidrosis, it is usually reversible with the discontinuation of the medication. Anhydrosis secondary to a treatable cause is generally reversible and has a favorable prognosis.</p>
      </sec>
      <sec id="article-32720.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications will depend on the underlying etiology. Heat-related illnesses are the most&#x000a0;grave complications of anhidrosis. Children are more vulnerable because their core body temperature rises faster than adults and their heat loss mechanism is less efficient. Heat-related illnesses are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Heat cramps</p>
          </list-item>
          <list-item>
            <p>Heat exhaustion</p>
          </list-item>
          <list-item>
            <p>Heatstroke</p>
          </list-item>
        </list>
        <p>The most feared complication, no matter the underlying etiology, is heatstroke.</p>
      </sec>
      <sec id="article-32720.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Providers need to stress the importance of maintaining a cool environment for the patient.&#x000a0;The use of&#x000a0;water spray bottles for purposes of cooling can prove helpful. The patient is advised to wear loose and light clothing when it is warm and monitor their activity level not to overdo it. Frequent and gentle exfoliation is helpful for those disorders due to clogged sweat glands.</p>
      </sec>
      <sec id="article-32720.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional approach to&#x000a0;anhidrosis&#x000a0;is recommended. Anhidrosis and the underlying etiologies&#x000a0;can cause severe emotional distress for patients. Quality of life may be low for patients of all ages secondary to societal scrutinization of their underlying condition (i.e., lamellar ichthyosis). Therefore, it is&#x000a0;recommended&#x000a0;to evaluate and arrange for mental health care in addition to the necessary medical care to address the underlying cause of the&#x000a0;anhidrosis, if there is one. The outcome of patients with&#x000a0;anhidrosis&#x000a0;depends on the cause. There is no cure for those with inherited disorders, and it is a lifelong issue. The outcomes may improve for those with acquired&#x000a0;anhidrosis by improving the primary condition&#x000a0;or removing the offending medication. Most importantly, the patient should be actively involved in their care as the patient must maintain a cool environment and recognize the signs and symptoms of heat intolerance.</p>
      </sec>
      <sec id="article-32720.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=32720&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=32720">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/anhidrosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=32720">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/32720/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=32720">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-32720.s16">
        <title>References</title>
        <ref id="article-32720.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gauer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meyers</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Heat-Related Illnesses.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Apr</month>
            <day>15</day>
            <volume>99</volume>
            <issue>8</issue>
            <fpage>482</fpage>
            <page-range>482-489</page-range>
            <pub-id pub-id-type="pmid">30990296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gagnon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Crandall</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Sweating as a heat loss thermoeffector.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2018</year>
            <volume>156</volume>
            <fpage>211</fpage>
            <page-range>211-232</page-range>
            <pub-id pub-id-type="pmid">30454591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Saga</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Biology of sweat glands and their disorders. II. Disorders of sweat gland function.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1989</year>
            <month>May</month>
            <volume>20</volume>
            <issue>5 Pt 1</issue>
            <fpage>713</fpage>
            <page-range>713-26</page-range>
            <pub-id pub-id-type="pmid">2654213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Budania</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bharti</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Clinical and laboratory correlates of selective autonomic dysfunction due to Ross syndrome.</article-title>
            <source>J Family Med Prim Care</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>1500</fpage>
            <page-range>1500-1503</page-range>
            <pub-id pub-id-type="pmid">31143750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenzel</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Horn</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Nonneoplastic disorders of the eccrine glands.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-17; quiz 18-20</page-range>
            <pub-id pub-id-type="pmid">9448199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoo</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Koong</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Ipsilateral Hyperhidrosis: Atypical Symptom of Small Lung Adenocarcinoma Evaluated by <sup>18</sup>F-FDG PET-CT.</article-title>
            <source>Nucl Med Mol Imaging</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>231</fpage>
            <page-range>231-234</page-range>
            <pub-id pub-id-type="pmid">31231444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fealey</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Thermoregulation in neuropathies.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2018</year>
            <volume>157</volume>
            <fpage>777</fpage>
            <page-range>777-787</page-range>
            <pub-id pub-id-type="pmid">30459040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwartzlow</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kazamel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification.</article-title>
            <source>Curr Neurol Neurosci Rep</source>
            <year>2019</year>
            <month>Jun</month>
            <day>20</day>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>52</fpage>
            <pub-id pub-id-type="pmid">31222456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic and genotypic features of a pair of Chinese identical twins with congenital insensitivity to pain and anhidrosis: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>97</volume>
            <issue>47</issue>
            <fpage>e13209</fpage>
            <pub-id pub-id-type="pmid">30461622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mack</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>A model for in vivo analysis of sudomotor sympathetic C-fiber activation and human sweat gland output.</article-title>
            <source>J Appl Physiol (1985)</source>
            <year>2017</year>
            <month>Aug</month>
            <day>01</day>
            <volume>123</volume>
            <issue>2</issue>
            <fpage>317</fpage>
            <page-range>317-325</page-range>
            <pub-id pub-id-type="pmid">28522768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Asano</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yasuno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shimomura</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Functional studies for a dominant mutation in the EDAR gene responsible for hypohidrotic ectodermal dysplasia.</article-title>
            <source>J Dermatol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>8</issue>
            <fpage>710</fpage>
            <page-range>710-715</page-range>
            <pub-id pub-id-type="pmid">31245878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Gotmare</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Khare</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Hypohydrotic Ectodermal Dysplasia in an Indian Family.</article-title>
            <source>J Coll Physicians Surg Pak</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>381</fpage>
            <page-range>381-383</page-range>
            <pub-id pub-id-type="pmid">30925967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Natural history of the Naegeli-Franceschetti-Jadassohn syndrome.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>5 Pt 1</issue>
            <fpage>830</fpage>
            <pub-id pub-id-type="pmid">7929942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siedler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>K&#x000e1;hn</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Weidemann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wanner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sommer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>&#x000dc;&#x000e7;eyler</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dyshidrosis is associated with reduced amplitudes in electrically evoked pain-related potentials in women with Fabry disease.</article-title>
            <source>Clin Neurophysiol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>528</fpage>
            <page-range>528-536</page-range>
            <pub-id pub-id-type="pmid">30785009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r15">
          <label>15</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Guerra</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Toncar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krishnamurthy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Miliaria</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">30725861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Diehl</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leavitt</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mohney</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Incidence of pediatric Horner syndrome and the risk of neuroblastoma: a population-based study.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>324</fpage>
            <page-range>324-9</page-range>
            <pub-id pub-id-type="pmid">20212203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kucur</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ozbay</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Oghan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yildirim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zeybek Sivas</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Canbaz Kabay</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A Rare Complication of Radiofrequency Tonsil Ablation: Horner Syndrome.</article-title>
            <source>Case Rep Otolaryngol</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>570520</fpage>
            <pub-id pub-id-type="pmid">26064747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Itin</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Burger</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous fading of reticular pigmentation in Naegeli-Franceschetti-Jadassohn syndrome.</article-title>
            <source>Dermatology</source>
            <year>2010</year>
            <volume>221</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-6</page-range>
            <pub-id pub-id-type="pmid">20587992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whittock</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Ashton</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Acland</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Eady</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The gene for Naegeli-Franceschetti-Jadassohn syndrome maps to 17q21.</article-title>
            <source>J Invest Dermatol</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>115</volume>
            <issue>4</issue>
            <fpage>694</fpage>
            <page-range>694-8</page-range>
            <pub-id pub-id-type="pmid">10998145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eyskens</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Feliciani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kantola</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ramaswami</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Rolfs</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Waldek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Germain</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Fabry disease: a review of current management strategies.</article-title>
            <source>QJM</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>103</volume>
            <issue>9</issue>
            <fpage>641</fpage>
            <page-range>641-59</page-range>
            <pub-id pub-id-type="pmid">20660166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saito</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The location and characteristics of the thermal sudomotor pathways in the human brainstem: A reappraisal.</article-title>
            <source>Auton Neurosci</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>217</volume>
            <fpage>80</fpage>
            <page-range>80-90</page-range>
            <pub-id pub-id-type="pmid">30744906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reede</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Garcon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Smoker</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Kardon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Horner's syndrome: clinical and radiographic evaluation.</article-title>
            <source>Neuroimaging Clin N Am</source>
            <year>2008</year>
            <month>May</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>369</fpage>
            <page-range>369-85, xi</page-range>
            <pub-id pub-id-type="pmid">18466837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Asahina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Uehara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Araki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Okuyama</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Degranulation and shrinkage of dark cells in eccrine glands and elevated serum carcinoembryonic antigen in patients with acquired idiopathic generalized anhidrosis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>12</issue>
            <fpage>2097</fpage>
            <page-range>2097-2103</page-range>
            <pub-id pub-id-type="pmid">28662305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakabe</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Kabashima-Kubo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tokura</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis.</article-title>
            <source>J Invest Dermatol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>134</volume>
            <issue>1</issue>
            <fpage>276</fpage>
            <page-range>276-279</page-range>
            <pub-id pub-id-type="pmid">23748235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Illigens</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Gibbons</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Sweat testing to evaluate autonomic function.</article-title>
            <source>Clin Auton Res</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-87</page-range>
            <pub-id pub-id-type="pmid">18989618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfe</surname>
                <given-names>GI</given-names>
              </name>
              <name>
                <surname>Galetta</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Teener</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Site of autonomic dysfunction in a patient with Ross' syndrome and postganglionic Horner's syndrome.</article-title>
            <source>Neurology</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>2094</fpage>
            <page-range>2094-6</page-range>
            <pub-id pub-id-type="pmid">7501165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loavenbruck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wendelschaefer-Crabbe</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sandroni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Quantification of sweat gland volume and innervation in neuropathy: Correlation with thermoregulatory sweat testing.</article-title>
            <source>Muscle Nerve</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>50</volume>
            <issue>4</issue>
            <fpage>528</fpage>
            <page-range>528-34</page-range>
            <pub-id pub-id-type="pmid">24449525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32720.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohshima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yanagishita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tamada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Inukai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iwase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sugenoya</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Treatment of patients with acquired idiopathic generalized anhidrosis.</article-title>
            <source>Br J Dermatol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>168</volume>
            <issue>2</issue>
            <fpage>430</fpage>
            <page-range>430-2</page-range>
            <pub-id pub-id-type="pmid">22709381</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
